3 ms·
Yes but you'd only buy out the Covid-19 IP, not the whole company. And $100B is a small part of what we've spent fighting this pandemic.
by spoonjim 5y ago
Yes but you'd only buy out the Covid-19 IP, not the whole company. And $100B is a small part of what we've spent fighting this pandemic.
- rp1 5y agoI don’t think you can separate the COVID IP from their other IP as all of their IP is based on manufacturing lipid nanoparticle delivery vessels. If you took this IP, this rest wouldn’t be worth very much.